IN2004CH02747A - - Google Patents

Info

Publication number
IN2004CH02747A
IN2004CH02747A IN2747CH2004A IN2004CH02747A IN 2004CH02747 A IN2004CH02747 A IN 2004CH02747A IN 2747CH2004 A IN2747CH2004 A IN 2747CH2004A IN 2004CH02747 A IN2004CH02747 A IN 2004CH02747A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Karl Schoenafinger
Elisabeth Defossa
Dieter Kadereit
Roedern Erich Von
Thomas Klabunde
Hans-Joerg Burger
Andreas Herling
Karl-Ulrich Wendt
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of IN2004CH02747A publication Critical patent/IN2004CH02747A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN2747CH2004 2002-06-07 2004-12-06 IN2004CH02747A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10225635A DE10225635C1 (de) 2002-06-07 2002-06-07 N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung

Publications (1)

Publication Number Publication Date
IN2004CH02747A true IN2004CH02747A (zh) 2006-02-10

Family

ID=29594346

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2747CH2004 IN2004CH02747A (zh) 2002-06-07 2004-12-06

Country Status (26)

Country Link
EP (1) EP1513800B1 (zh)
JP (1) JP4398859B2 (zh)
KR (1) KR20050004295A (zh)
CN (1) CN1659137A (zh)
AT (1) ATE345326T1 (zh)
AU (1) AU2003238373A1 (zh)
BR (1) BR0311646A (zh)
CA (1) CA2488760A1 (zh)
CY (1) CY1106003T1 (zh)
DE (2) DE10225635C1 (zh)
DK (1) DK1513800T3 (zh)
ES (1) ES2277082T3 (zh)
HR (1) HRPK20041161B3 (zh)
IL (1) IL165558A0 (zh)
IN (1) IN2004CH02747A (zh)
MA (1) MA27232A1 (zh)
MX (1) MXPA04011984A (zh)
NO (1) NO20050087L (zh)
NZ (1) NZ537004A (zh)
PL (1) PL372117A1 (zh)
PT (1) PT1513800E (zh)
RU (1) RU2004139122A (zh)
SI (1) SI1513800T1 (zh)
TW (1) TW200404763A (zh)
WO (1) WO2003104188A1 (zh)
ZA (1) ZA200408887B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10302452B4 (de) * 2003-01-23 2005-02-24 Aventis Pharma Deutschland Gmbh Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
US7179941B2 (en) 2003-01-23 2007-02-20 Sanofi-Aventis Deutschland Gmbh Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
DE10306502B4 (de) * 2003-02-17 2005-03-17 Aventis Pharma Deutschland Gmbh Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10335092B3 (de) 2003-08-01 2005-02-03 Aventis Pharma Deutschland Gmbh Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
US7241787B2 (en) 2004-01-25 2007-07-10 Sanofi-Aventis Deutschland Gmbh Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
WO2006055435A1 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
US7365061B2 (en) 2004-11-15 2008-04-29 Bristol-Myers Squibb Company 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7214704B2 (en) 2004-11-15 2007-05-08 Bristol-Myers Squibb Company 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006055462A1 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
TW200718691A (en) 2005-06-10 2007-05-16 Sigma Tau Ind Farmaceuti Cinnamic and phenylpropiolic acid derivatives useful as anti-tumour agents
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL141381B (nl) * 1963-09-25 1974-03-15 Hoechst Ag Werkwijze voor het bereiden van geneesmiddelen met bloedsuikerspiegel verlagende werkzaamheid.
IE860511L (en) * 1985-03-01 1986-09-01 Alfa Farmaceutici Spa "Benzoyl urea derivatives having anti-tumor activity"
ZA867420B (en) * 1985-09-30 1987-05-27 Union Carbide Corp Pesticidal 1-(4-aryloxyphenyl)-3-benzoyl urea compounds and process for preparation
DE4037112A1 (de) * 1990-11-22 1992-05-27 Thomae Gmbh Dr K Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
MX9709874A (es) * 1995-06-06 1998-03-31 Pfizer N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
GT200100039A (es) * 2000-03-16 2001-12-31 Pfizer Inhibidor de la glucogeno fosforilasa.
NZ523034A (en) * 2000-06-09 2004-07-30 Aventis Pharma Gmbh Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
EP1513800A1 (de) 2005-03-16
ES2277082T3 (es) 2007-07-01
TW200404763A (en) 2004-04-01
PL372117A1 (en) 2005-07-11
WO2003104188A1 (de) 2003-12-18
ATE345326T1 (de) 2006-12-15
NO20050087L (no) 2005-01-06
MXPA04011984A (es) 2005-03-07
ZA200408887B (en) 2005-11-23
DE10225635C1 (de) 2003-12-24
NZ537004A (en) 2006-06-30
CN1659137A (zh) 2005-08-24
EP1513800B1 (de) 2006-11-15
DK1513800T3 (da) 2007-03-26
DE50305693D1 (de) 2006-12-28
JP4398859B2 (ja) 2010-01-13
JP2005529164A (ja) 2005-09-29
SI1513800T1 (sl) 2007-04-30
AU2003238373A1 (en) 2003-12-22
RU2004139122A (ru) 2005-06-10
BR0311646A (pt) 2005-03-15
IL165558A0 (en) 2006-01-15
MA27232A1 (fr) 2005-02-01
HRP20041161A2 (en) 2005-04-30
HRPK20041161B3 (en) 2006-09-30
PT1513800E (pt) 2007-02-28
CA2488760A1 (en) 2003-12-18
KR20050004295A (ko) 2005-01-12
CY1106003T1 (el) 2011-04-06

Similar Documents

Publication Publication Date Title
BE2019C547I2 (zh)
BE2019C510I2 (zh)
BE2018C021I2 (zh)
BE2017C049I2 (zh)
BE2017C005I2 (zh)
BE2016C069I2 (zh)
BE2016C040I2 (zh)
BE2016C013I2 (zh)
BE2018C018I2 (zh)
BE2016C002I2 (zh)
BE2015C017I2 (zh)
BE2014C053I2 (zh)
BE2014C051I2 (zh)
BE2014C041I2 (zh)
BE2014C030I2 (zh)
BE2014C016I2 (zh)
BE2015C067I2 (zh)
BRPI0215435A2 (zh)
JP2003255507A5 (zh)
DE50212121D1 (zh)
HU0201065D0 (zh)
JP2003102798A5 (zh)
JP2003202494A5 (zh)
JP2002322988A5 (zh)
JP2003167190A5 (zh)